No. It's this amendment here. I think the other ones that I'm prepared to drop are going to enhance certain elements of the bill. I would point to the food and drugs and safety act amendments in particular, because concern was raised about Health Canada saying that it would not be part of the process to look at drugs for export. We've already said, for example, that's off the table, so that's off the table and the objections from Health Canada are off the table. Objections from any member here about Health Canada drugs going out are off the table.
The others, the changes to the website and a whole series of reporting changes and so forth, were seen by other members and the department as not being good ideas. Facing that, we're willing to go back to the other parts of the bill. There will be some reporting things that water down even what I'm suggesting by keeping the one licence and one solution. But it's still better than what we have. If we go ahead with this amendment, it will gut the bill significantly.
Lib-3 is problematic as well. We might have a solution for that.
But at any rate, I think this is critical. If we don't defeat this amendment, it will all be for naught. We've heard that in the testimony from the non-governmental agencies and we've heard it from the generics that wanted to try to use this. It's about making sure that the preconditions by which a country can procure medicines are done in a way such that they can do so without intimidation, without fear, and according to the needs of their nation. Then we will still follow a lot of the regimental regime behind CAMR that was originally created in the first legislation.